Skip to main content

4 Result(s)

within Changhu Chen Remove this filter English Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Outcomes of symptomatic compared to asymptomatic recurrences in patients with glioblastoma multiforme (GBM)

    Glioblastoma multiforme (GBM) is a nearly uniformly fatal brain tumor with a median recurrence rate of 7 months and survival of 14 months after multimodality treatment. We sought to evaluate outcomes based on ...

    Arya Amini, Basel Altoos, Sana D. Karam… in Journal of Radiation Oncology (2016)

  2. No Access

    Article

    Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials

    To compare progression-free (PFS) and overall survival (OS) in patients treated in two consecutive phase II trials of hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with o...

    Julie A. Carlson, Krishna Reddy, Laurie E. Gaspar, Douglas Ney… in Journal of Neuro-Oncology (2015)

  3. No Access

    Article

    Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma

    Bevacizumab blocks the effects of VEGF and may allow for more aggressive radiotherapy schedules. We evaluated the efficacy and toxicity of hypofractionated intensity-modulated radiation therapy with concurrent...

    Douglas E. Ney, Julie A. Carlson, Denise M. Damek… in Journal of Neuro-Oncology (2015)

  4. No Access

    Article

    Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide

    To report health-related quality of life (HRQOL) in glioblastoma (GBM) patients treated on a phase II trial of hypofractionated intensity-modulated radiotherapy (hypo-IMRT) with temozolomide (TMZ). GBM patient...

    Krishna Reddy, Laurie E. Gaspar, Brian D. Kavanagh… in Journal of Neuro-Oncology (2013)